1. Clinical benefit of treatment with eribulin mesylate for metastatic triple‐negative breast cancer: Long‐term outcomes of patients treated in the US community oncology setting. (31st July 2018) Authors: Mougalian, Sarah S.; Copher, Ronda; Kish, Jonathan K.; McAllister, Lindsay; Wang, Zhixiao; Broscious, Mary; Garofalo, David; Radtchenko, Janna; Feinberg, Bruce A. Journal: Cancer medicine Issue: Volume 7:Number 9(2018:Sep.) Page Start: 4371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗